Results 261 to 270 of about 8,117 (271)

A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis

American Journal of Rhinology and Allergy, 2021
Kenji Kondo, Kenzo Tsuzuki, Kunihiko Shibata   +2 more
exaly  

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab

Drug Safety, 2020
David J Jackson, Sameer Mathur, Ubaldo J Martin   +2 more
exaly  

Benralizumab Reduces Asthma Worsening Episodes

D101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD, 2019
C.A. Da Silva, Malin Fagerås, James Zangrilli, Lieke E.J.M. Scheepers, Tim Harrison, Alexandra Jauhiainen, Anne L. Fuhlbrigge   +6 more
openaire   +1 more source

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma

Advances in Therapy, 2020
David J Jackson, Marc Humbert, Ian Hirsch   +2 more
exaly  

Benralizumab (Fasenra) for Severe Eosinophilic Asthma

JAMA, 2018
openaire   +2 more sources

Allergic bronchopulmonary aspergillosis successfully treated with benralizumab

The Journal of Allergy and Clinical Immunology: In Practice, 2019
Yuta Kono, Masako To, Otohiro Katsube, Yasuo To, Satoshi Yamawaki, Ryuta Tsuzuki, Seiko Soeda   +6 more
openaire   +3 more sources

A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma

American Journal of Emergency Medicine, 2015
Brian H Rowe
exaly  

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

European Respiratory Journal, 2018
Eugene R Bleecker, Mohsen Sadatsafavi, Andrew Menzies-gow   +2 more
exaly  

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

New England Journal of Medicine, 2017
Parameswaran Nair, Sally E Wenzel, Klaus F Rabe   +2 more
exaly  

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

Current Medical Research and Opinion, 2017
Ian Hirsch
exaly